|
WO2020180980A1
|
|
Medium chain triglyceride formulations with improved bioavailiblity and methods related thereto
|
|
EP3765002A1
|
|
Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
|
|
EP3595638A1
|
|
Pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto
|
|
AU2014259587A1
|
|
Use of genomic testing and ketongenic compounds for treatment of reduced cognitive function
|
|
AU2009266869A1
|
|
Monoglyceride of acetoacetate and derivatives for the treatment of neurological disorders
|
|
AU2008282130A1
|
|
Use of genomic testing and ketogenic compounds for treatment of reduced cognitive function
|
